Spire Wealth Management’s Allena Pharmaceuticals ALNA Stock Holding History

Spire Wealth Management’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,053	Closed	-$2K	–	2729
2022 Q2	$2K	Buy	10,053 +53	+0.5%	+$8	﹤0.01%	2441
2022 Q1	$2K	Sell	10,000 -81,940	-89%	-$33.9K	﹤0.01%	2447
2021 Q4	$54K	Buy	91,940 +41,940	+84%	+$32.8K	﹤0.01%	1691
2021 Q3	$45K	Buy	+50,000	New	+$49K	﹤0.01%	1519

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Spire Wealth Management's ALNA Position: Q3 2022 in Review

Spire Wealth Management sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 10,053 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in ALNA in Q3 2021 and held it in 4 quarters. The position peaked at $54K in Q4 2021. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Spire Wealth Management reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Spire Wealth Management sold 10,053 Allena Pharmaceuticals shares in Q3 2022, an estimated $2K.
Spire Wealth Management first reported a position in Allena Pharmaceuticals in Q3 2021 and held it in 4 quarters.
Spire Wealth Management's Allena Pharmaceuticals position peaked at $54K in Q4 2021.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.